Lepirudin blunts endotoxin-induced coagulation activation.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Blood

• Publication date

  2000-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V95.5.1729.005K16_1729_1734PMID 10688831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of the administration of recombinant hirudin and/or tissue‐plasminogen activator (t‐PA) on endotoxin‐induced disseminated intravascular coagulation model in rabbits

  1999cited by this paper
• Comparison of the antithrombotic effect of PEG-hirudin and heparin in a human ex vivo model of arterial thrombosis.

  1999cited by this paper
• Heparin blunts endotoxin-induced coagulation activation.

  1999cited by this paper
• Disseminated Intravascular Coagulation

  1999cited by this paper
• Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen.

  1999cited by this paper
• Effects of Endotoxemia on Thrombopoiesis in Men

  1999cited by this paper
• Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries.

  1998cited by this paper
• The haematological manifestations of sepsis.

  1998cited by this paper
• Current Drug Treatment Strategies for Disseminated Intravascular Coagulation

  1998cited by this paper
• Differential effect of unfractionated heparin and low molecular weight heparin on intravascular tissue factor pathway inhibitor: evidence for a difference in antithrombotic action

  1998cited by this paper
• Endotoxin-induced disseminated intravascular coagulation in rabbits: effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality.

  1998cited by this paper
• The cytokine‐mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia

  1997cited by this paper
• Modulation of cytokine release and neutrophil function by granulocyte colony-stimulating factor during endotoxemia in humans.

  1997cited by this paper
• Dexamethasone down‐regulates the expression of L‐selectin on the surface of neutrophils and lymphocytes in humans*

  1997cited by this paper
• The thrombin inhibitor, hirudin, attenuates lipopolysaccharide-induced liver injury in the rat.

  1996cited by this paper
• The Importance of Platelets in the Expression of Monocyte Tissue Factor Antigen Measured by a New Whole Blood Flow Cytometric Assay

  1996cited by this paper
• A recombinant hirudin (IK-HIR02) in healthy volunteers. II. Effects on platelet adhesion and platelet-induced thrombin generation time.

  1996cited by this paper
• Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial.

  1996cited by this paper
• Depletion of Intravascular Pools of Tissue Factor Pathway Inhibitor (TFPI) during Repeated or Continuous Intravenous Infusion of Heparin in Man

  1996cited by this paper
• Distinct effects of recombinant desulfatohirudin (Revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina. A multicenter trial.

  1996cited by this paper
• Initiation of the tissue factor pathway of coagulation in the presence of heparin: control by antithrombin III and tissue factor pathway inhibitor.

  1996cited by this paper
• Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.

  1995cited by this paper
• Effects of recombinant hirudin (r-hirudin, HBW 023) on coagulation and platelet activation in vivo. Comparison with unfractionated heparin and a low-molecular-weight heparin preparation (fragmin).

  1995cited by this paper
• Recombinant hirudin for the treatment of disseminated intravascular coagulation in patients with haematological malignancy

  1995cited by this paper
• A novel biological effect of platelet factor 4 (PF4): enhancement of LPS‐induced tissue factor activity in monocytes

  1995cited by this paper
• Advances in Antithrombotic Therapy: Novel Agents

  1995cited by this paper
• Persistent Thrombin Generation in Humans During Specific Thrombin Inhibition With Hirudin

  1994cited by this paper
• Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.

  1994cited by this paper
• Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees.

  1994cited by this paper
• Laboratory methods for detecting disseminated intravascular coagulation (DIC): new aspects

  1993cited by this paper
• Pathogenesis of disseminated intravascular coagulation in sepsis.

  1993cited by this paper
• Response of man to endotoxin.

  1993cited by this paper
• Platelet activating factor enhancement of lipopolysaccharide‐induced tissue factor activity in monocytes: requirement of platelets and granulocytes

  1992cited by this paper
• Modulators of coagulation. A critical appraisal of their role in sepsis.

  1992cited by this paper
• Determination of soluble fibrin: a comparison of four different methods.

  1992cited by this paper
• Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol

  1991cited by this paper
• Drug therapy : heparin

  1991cited by this paper
• Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways.

  1990cited by this paper
• Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

  1990cited by this paper
• The cardiovascular response of normal humans to the administration of endotoxin.

  1989cited by this paper
• Determination of Soluble Fibrin in Plasma by a Rapid and Quantitative Spectrophotometric Assay

  1986cited by this paper

• Pathways regulating the release of tissue factor-positive extracellular vesicles and activation of coagulation in endotoxemic mice.

  2025cites this paper
• Disseminated intravascular coagulation: epidemiology, biomarkers, and management

  2021cites this paper
• Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel

  2020cites this paper
• Human lipopolysaccharide models provide mechanistic and therapeutic insights into systemic and pulmonary inflammation

  2020cites this paper
• Defibrotide enhances fibrinolysis in human endotoxemia – a randomized, double blind, crossover trial in healthy volunteers

  2019cites this paper
• Coagulative biomarkers on admission to the ICU predict acute kidney injury and mortality in patients with septic shock caused by intra-abdominal infection

  2019cites this paper
• Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies

  2018cites this paper
• Dual inhibition of thrombin and activated factor X attenuates disseminated intravascular coagulation and protects organ function in a baboon model of severe Gram-negative sepsis

  2017cites this paper
• A Dormant Microbial Component in the Development of Pre-Eclampsia

  2016cites this paper
• A Dormant Microbial Component in the Development of Preeclampsia

  2016cites this paper
• Fucoidan Extracted from Fucus Evanescens Prevents Endotoxin-Induced Damage in a Mouse Model of Endotoxemia

  2014cites this paper
• associated with enhanced coagulation during human endotoxemia The single nucleotide polymorphism Ser128Arg in the E-selectin gene is

  2013cites this paper
• severe protein C deficiency Acute inflammation is exacerbated in mice genetically predisposed to a

  2013cites this paper
• Establishment of a Low Dose Canine Endotoxemia Model to Test Anti-Inflammatory Drugs: Effects of Prednisolone

  2013cites this paper
• Differential ability of tissue factor antibody clones on detection of tissue factor in blood cells and microparticles.

  2012cites this paper
• Thrombin as a multi-functional enzyme

  2011cites this paper
• Factor V Leiden mutation enhances fibrin formation and dissolution in vivo in a human endotoxemia model.

  2010cites this paper
• Heparin protects against septic mortality via apoE-antagonism.

  2010cites this paper
• IJPP Hemotology 9-2-08

  2009cites this paper
• Racial differences in endotoxin‐induced tissue factor‐triggered coagulation

  2009cites this paper
• Inhibition of Thrombin in Cardiac Surgery : experiments in a porcine model

  2009influential citation
• Fucoidan Extracted from Fucus Evanescens Brown Algae Corrects Immunity and Hemostasis Disorders in Experimental Endotoxemia

  2009cites this paper
• Studies on pathophysiological mechanisms in experimental models of acute renal failure

  2007influential citation
• Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency.

  2007cites this paper
• The role of heparin and allied compounds in the treatment of sepsis

  2007cites this paper
• Pharmacokinetics and Pharmacodynamics of the Dual FII/FX Inhibitor BIBT 986 in Endotoxin‐induced Coagulation

  2007cites this paper
• Effect of Combined Anticoagulation Using Heparin and Bivalirudin on the Hemostatic and Inflammatory Responses to Cardiopulmonary Bypass in the Rat

  2007cites this paper
• Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulation

  2007cites this paper
• Effects of low dose endotoxemia on endothelial progenitor cells in humans.

  2007cites this paper
• Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans

  2006cites this paper
• Obesity and Sepsis

  2006cites this paper
• Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation

  2006cites this paper
• A coagulation factor VII deficiency protects against acute inflammatory responses in mice

  2006cites this paper
• Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia

  2006cites this paper
• Coagulation interventions in experimental human endotoxemia.

  2006cites this paper
• Effects of carbon monoxide inhalation during experimental endotoxemia in humans.

  2005cites this paper
• The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia

  2005cites this paper
• The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia.

  2005cites this paper
• Direct thrombin inhibitors: pharmacology and clinical relevance

  2005cites this paper
• Endotoxemia enhances expression of the signaling receptor (GP130) on protein and molecular level.

  2005cites this paper
• Pathophysiology, diagnosis and treatment of disseminated intravascular coagulation: an update.

  2005cites this paper
• Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation

  2005cites this paper
• New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated)

  2005cites this paper
• Effects of recombinant human activated protein C in human models of endotoxin administration.

  2005cites this paper
• Coagulation activation in sepsis

  2005cites this paper
• Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia.

  2004cites this paper
• Effects of Drotrecogin Alfa (Activated) in Human Endotoxemia

  2004cites this paper
• Coagulopathy of sepsis

  2004cites this paper
• Human models of endotoxemia and recombinant human activated protein C

  2004cites this paper
• Update on the Treatment of Disseminated Intravascular Coagulation

  2004cites this paper
• Recombinant hirudin enhances cardiac output and decreases systemic vascular resistance during reperfusion after cardiopulmonary bypass in a porcine model.

  2004cites this paper
• Effects of Two Tetrahydroisoquinolines (YS-49 and YS-51) on Experimental Disseminated Intravascular Coagulation Induced by Lipopolysaccharide in Rats

  2004cites this paper
• Validation of a novel tissue factor assay in experimental human endotoxemia.

  2003cites this paper
• dysfunction syndrome The role of the endothelium in severe sepsis and multiple organ

  2003cites this paper
• Marked increase in vascular endothelial growth factor concentrations during Escherichia coli endotoxin‐induced acute inflammation in humans

  2003cites this paper
• Recent developments in the treatment of sepsis

  2003cites this paper
• Recombinant human activated protein C (rhAPC; drotrecogin alfa [activated]) has minimal effect on markers of coagulation, fibrinolysis, and inflammation in acute human endotoxemia.

  2003cites this paper
• Infection and inflammation and the coagulation system.

  2003cites this paper
• Methods for the monitoring of direct thrombin inhibitors.

  2002cites this paper
• Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model

  2002cites this paper
• Point of care measurement of lepirudin and heparin anticoagulation during systemic inflammation.

  2002cites this paper
• Evaluation of coagulation markers for early diagnosis of acute coronary syndromes in the emergency room.

  2002cites this paper
• Utilisation en pratique des marqueurs biologiques de la coagulation et de la fibrinolyse

  2002cites this paper
• Acenocoumarol decreases tissue factor–dependent coagulation during systemic inflammation in humans

  2002cites this paper
• Pharmacodynamics of active site‐inhibited factor VIIa in endotoxin‐induced coagulation in humans

  2002cites this paper
• Marked difference in pathophysiology between tissue factor- and lipopolysaccharide-induced disseminated intravascular coagulation models in rats

  2002cites this paper
• Effect of factor X inhibition on coagulation activation and cytokine induction in human systemic inflammation.

  2002influential citation
• Methods for the Monitoring of Direct Thrombin Inhibitors

  2002cites this paper
• Effects of anticoagulation on thrombopoietin release during endotoxemia.

  2001cites this paper
• Vascular bed-specific hemostasis: Role of endothelium in sepsis pathogenesis

  2001cites this paper
• Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.

  2001cites this paper
• Fibrin Degradation Products, Fibrin Monomer and Soluble Fibrin in Disseminated Intravascular Coagulation

  2001cites this paper
• All-trans retinoic acid is partially effective against lipopolysaccharide-induced but not against tissue-factor-induced disseminated intravascular coagulation in rat models

  2001cites this paper
• Beneficial Effect of the Active Form of Vitamin D3 against LPS-induced DIC but not against Tissue-factor-induced DIC in Rat Models

  2001cites this paper
• Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy.

  2000cites this paper